Du Y, Choi S, Pilski A, Graves S
Front Cell Neurosci. 2022; 16:949923.
PMID: 35936499
PMC: 9354074.
DOI: 10.3389/fncel.2022.949923.
Matschke L, Komadowski M, Stohr A, Lee B, Henrich M, Griesbach M
Sci Rep. 2022; 12(1):3180.
PMID: 35210472
PMC: 8873463.
DOI: 10.1038/s41598-022-06832-1.
Fan Y, Zeng F, Brown R, Price J, Jones T, Zhu M
Neurotox Res. 2020; 38(3):793-807.
PMID: 32617854
PMC: 7484387.
DOI: 10.1007/s12640-020-00250-9.
Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C
Front Pharmacol. 2020; 11:435.
PMID: 32322208
PMC: 7157437.
DOI: 10.3389/fphar.2020.00435.
Zhu M, Raza M, Zhan Y, Fan Y
Neurochem Int. 2019; 131:104549.
PMID: 31539561
PMC: 6886695.
DOI: 10.1016/j.neuint.2019.104549.
Cell Densities in the Mouse Brain: A Systematic Review.
Keller D, Ero C, Markram H
Front Neuroanat. 2018; 12:83.
PMID: 30405363
PMC: 6205984.
DOI: 10.3389/fnana.2018.00083.
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich M, Geibl F, Lee B, Chiu W, Koprich J, Brotchie J
Acta Neuropathol Commun. 2018; 6(1):39.
PMID: 29747690
PMC: 5946574.
DOI: 10.1186/s40478-018-0541-1.
Noradrenergic Modulation on Dopaminergic Neurons.
Zhu M
Neurotox Res. 2018; 34(4):848-859.
PMID: 29572781
DOI: 10.1007/s12640-018-9889-z.
Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson's disease model by inhibiting microglial M1 polarization.
Hou L, Che Y, Sun F, Wang Q
Amino Acids. 2018; 50(5):547-556.
PMID: 29508060
DOI: 10.1007/s00726-018-2547-1.
Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
Masilamoni G, Groover O, Smith Y
Neurobiol Dis. 2017; 100:9-18.
PMID: 28042095
PMC: 5511687.
DOI: 10.1016/j.nbd.2016.12.025.
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
Iravani M, Sadeghian M, Rose S, Jenner P
J Neural Transm (Vienna). 2014; 121(12):1493-505.
PMID: 24781752
DOI: 10.1007/s00702-014-1223-1.
Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration.
Szot P, Franklin A, Sikkema C, Wilkinson C, Raskind M
Front Pharmacol. 2012; 3:184.
PMID: 23129999
PMC: 3487487.
DOI: 10.3389/fphar.2012.00184.
Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.
Wang Q, Shin E, Nguyen X, Li Q, Bach J, Bing G
J Neuroinflammation. 2012; 9:124.
PMID: 22695044
PMC: 3409049.
DOI: 10.1186/1742-2094-9-124.
Heterogeneous responses to antioxidants in noradrenergic neurons of the Locus coeruleus indicate differing susceptibility to free radical content.
de Oliveira R, Gravina F, Lim R, Brichta A, Callister R, van Helden D
Oxid Med Cell Longev. 2012; 2012:820285.
PMID: 22577493
PMC: 3345253.
DOI: 10.1155/2012/820285.
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Barnum C, Bhide N, Lindenbach D, Surrena M, Goldenberg A, Tignor S
Pharmacol Biochem Behav. 2011; 100(3):607-15.
PMID: 21978941
PMC: 3242909.
DOI: 10.1016/j.pbb.2011.09.009.
L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
King J, Muthian G, Mackey V, Smith M, Charlton C
Life Sci. 2011; 89(17-18):638-43.
PMID: 21871902
PMC: 3189304.
DOI: 10.1016/j.lfs.2011.08.008.
Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.
Knaryan V, Samantaray S, Le Gal C, Ray S, Banik N
J Neurochem. 2011; 118(3):326-38.
PMID: 21615738
PMC: 3135734.
DOI: 10.1111/j.1471-4159.2011.07320.x.
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
McMillan P, White S, Franklin A, Greenup J, Leverenz J, Raskind M
Brain Res. 2010; 1373:240-52.
PMID: 21147074
PMC: 3038670.
DOI: 10.1016/j.brainres.2010.12.015.
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice.
Granholm A, Zaman V, Godbee J, Smith M, Ramadan R, Umphlet C
Brain Pathol. 2010; 21(3):330-48.
PMID: 20969653
PMC: 3042034.
DOI: 10.1111/j.1750-3639.2010.00457.x.
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.
Perez V, Marin C, Rubio A, Aguilar E, Barbanoj M, Kulisevsky J
J Neural Transm (Vienna). 2009; 116(10):1257-66.
PMID: 19710996
DOI: 10.1007/s00702-009-0291-0.
